Amongst the hype, real-world AI technology exists
ePrescribing: Progress and Opportunities
[embed]https://youtu.be/SinNiGgdJKI[/embed]
Opportunities to Improve Drug Price Transparency at the Point of Prescribing
By Tony Schueth, CEO and Managing Partner
Regulations and EHRs: All Pain and No Gain?
By Michael Burger, EDI and EHR Practice Lead
The Time is Right for Canada to Incorporate a Naming Convention for Biologics and Biosimilars into its Emerging ePrescribing Infrastructure
By Pooja Babbrah, Senior Consultant
Drug Price Transparency: Drivers at the Point of Prescribing
By Tony Schueth, CEO and Managing Partner
EHR Vendors: Are You Ready for Standards Changes Coming Soon to ePrescribing?
By Michael Burger, EHR and EDI Practice Lead
State and Federal Regulations Continue to Target the Opioid Epidemic and Part D Prescribing
By Keith Fisher, R.Ph. and Michelle Soble, R.Ph. Co-Leads, POCP Regulatory Resource Center
New NCPDP Specialty Pharmacy Workgroup to Meet on August 3
By Pooja Babbrah, Practice Lead, PBM Services
Should Data Sharing and Interoperability be Linked to Medicare Participation?
By Michael Burger, Practice Lead, EHRs and EDI
